This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
這位Mesoblast分析師不再看好；以下是週一的三大評級下調。
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
頂級華爾街分析師改變了他們對這些頂級股票的看法。有關所有分析師評級變動的完整信息，包括評級上調和下調，請查看我們的分析師評級頁面。
- Jefferies analyst David Stanton downgraded the rating for Mesoblast Limited (NASDAQ:MESO) from Buy to Hold. Mesoblast shares closed at $14.63 on Friday. See how other analysts view this stock.
- William Blair analyst Sami Corwin downgraded Applied Therapeutics, Inc. (NASDAQ:APLT) from Outperform to Market Perform. Applied Therapeutics shares closed at $0.8801 on Friday. See how other analysts view this stock.
- BTIG analyst Thomas Catherwood downgraded the rating for Innovative Industrial Properties, Inc. (NYSE:IIPR) from Buy to Neutral. NCR Atleos shares closed at $73.66 on Friday. See how other analysts view this stock.
- 傑富瑞分析師大衛·斯坦頓將Mesoblast Limited（納斯達克：MESO）的評級從買入下調爲持有。Mesoblast的股票在週五收於$14.63。看看其他分析師如何看待這隻股票。
- 威廉·布萊爾分析師薩米·科溫將Applied Therapeutics, Inc.（納斯達克：APLT）的評級從表現優於大盤下調至市場表現。Applied Therapeutics的股票在週五收於$0.8801。看看其他分析師如何看待這隻股票。
- BTIG分析師托馬斯·凱瑟伍德將Innovative Industrial Properties, Inc.（紐交所：IIPR）的評級從買入下調至中立。NCR Atleos的股票在週五收於$73.66。看看其他分析師如何看待這隻股票。
Considering buying MESO stock? Here's what analysts think:
考慮買入MESO股票嗎？以下是分析師的看法：
Read This Next:
接下來請閱讀：
- Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock
- 吉姆·克萊默喜歡沃爾瑪，推薦購買這隻「非常非常好」的金融股票
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間